CRISPR Gene Editing Technique Featured in Upcoming Myeloma Immunotherapy Trial
News
A Phase 1 clinical trial that uses the gene editing tool CRISPR to engineer multiple myeloma cellular immunotherapy will soon be underway at the University of Pennsylvania. The small ... Read more